A randomized phase II trial of adjuvant chemotherapy with uracil/tegafur and gemcitabine versus gemcitabine alone in patients with resected pancreatic cancer
β Scribed by Hideyuki Yoshitomi; Akira Togawa; Fumio Kimura; Hiroshi Ito; Hiroaki Shimizu; Hiroyuki Yoshidome; Masayuki Otsuka; Atsushi Kato; Satoshi Nozawa; Katsunori Furukawa; Masaru Miyazaki; Pancreatic Cancer Chemotherapy Program of the Chiba University Department of General Surgery Affiliated Hospital Group
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 128 KB
- Volume
- 113
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND The goals of the current study were to determine the safety and efficacy of a nonplatinumβcontaining doublet, gemcitabine and docetaxel, in the treatment of patients with chemotherapyβnaive nonsmall cell lung carcinoma (NSCLC). ## METHODS Thirtyβtwo patients with advanc
## Background: The combination of uracil and tegafur in a 4:1 molar concentration (uft) has a greater antitumor activity than 5-fluorouracil (5-fu) and tegafur. because the combination of 5-fu and cisplatin has been proven to have a synergistic antitumor effect in many experimental and clinical stu